Pre-screening with GeneXpert® MTB/RIF may increase use of isoniazid preventive therapy in antiretroviral programmes.
Lawn, Stephen D;
(2011)
Pre-screening with GeneXpert® MTB/RIF may increase use of isoniazid preventive therapy in antiretroviral programmes.
The international journal of tuberculosis and lung disease, 15 (9).
pp. 1272-1273.
ISSN 1027-3719
DOI: https://doi.org/10.5588/ijtld.11.0407
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
